Calidi Biotherapeutics's total assets for Q2 2024 were $6.43M, a decrease of -35.81% from the previous quarter. CLDI total liabilities were $18.18M for the fiscal quarter, a -0.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.